Method for making nanocomposite film

US2023414841A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2023414841-A1
Application numberUS-202318463335-A
CountryUS
Kind codeA1
Filing dateSep 8, 2023
Priority dateNov 3, 2020
Publication dateDec 28, 2023
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A health care and/or entertainment device protective film may be configured to contact human skin, e.g., to limit the transmission of infection by bacteria, fungi, protozoa, prions, and/or viruses. The film may be formed as a nanocomposite film including at least 75 wt. %, relative to total organic matrix weight, of polyethylene, silver particles, and TiO2 particles, wherein the silver particles and TiO2 particles are distributed within and/or on an outer surface of the polyethylene, wherein the silver particles have a size of 1 to 1,000 nm, and wherein the TiO2 particles have a size of 1 to 50 nm. Such films may be applied to health care and/or entertainment devices, including virtual reality googles.

First claim

Opening claim text (preview).

1 . (canceled) 2 . The method of claim 11 , wherein the nanocomposite film comprises, based on a total weight of the nanocomposite film: 1 to 5 wt. % of the silver particles; and 1 to 10 wt. % of the TiO 2 particles. 3 . The method of claim 11 , wherein a thickness of the outer surface of the organic matrix is in a range of from 0.025 to 25 μm. 4 . The method of claim 11 , wherein the polyethylene in the nanocomposite film is LDPE and is present in an amount of at least 97.5 wt. % relative to the relative to the total weight of the organic matrix. 5 . The method of claim 11 , wherein the polyethylene in the nanocomposite film has a melting point in a range of from 90 to 125° C. 6 . The method of claim 11 , wherein the polyethylene in the nanocomposite film has a density in a range of from 0.9 to 0.99 g/cm 3 . 7 . The method of claim 11 , wherein the TiO 2 particles in the nanocomposite film have an average longest dimension of no more than 25 nm, and/or wherein the TiO 2 particles have an average sphericity of at least 0.91. 8 . The method of claim 11 , wherein the polyethylene in the nanocomposite film is foamed. 9 . The method of claim 11 , wherein the nanocomposite film comprises no more than 2 wt. % of the silver particles. 10 . (canceled) 11 . A method for making a nanocomposite film, the method comprising: dispersing and thereby mixing polyethylene, silver particles, and TiO 2 particles in a solvent to form a dispersion; drying to form a dry mixture; and melt mixing the dry mixture to form the nanocomposite film; wherein the nanocomposite film comprises: an organic matrix comprising at least 75 wt. % of the polyethylene relative to a total weight of the organic matrix; the silver particles; and the TiO 2 particles, wherein the silver particles and the TiO 2 particles are distributed within and/or on an outer surface of the organic matrix, wherein the silver particles have a size of 1 to 1,000 nm, and wherein the TiO 2 particles have a size of 1 to 50 nm. 12 . The method of claim 11 , further comprising, prior to the dispersing: suspending the polyethylene in a first solvent for at least 5 minutes. 13 . The method of claim 12 , wherein the suspending of the polyethylene takes place for up to 12 hours. 14 . The method of claim 12 , wherein the first solvent comprises an alcohol. 15 . The method of claim 12 , wherein the first solvent comprises at least 75 wt. % of methanol, based on total solvent weight. 16 . The method of claim 11 , further comprising, prior to the dispersing: forming the silver particles in situ by reducing a silver precursor with a reducing agent. 17 . The method of claim 11 , wherein the melt mixing comprises heating at a temperature in a range of 10% of a melting point of the polyethylene, and/or wherein the melt mixing comprises heating at a temperature in a range of from 100 to 115° C. 18 - 20 . (canceled)

Assignees

Inventors

Classifications

  • A61L31/088Primary

    Other specific inorganic materials not covered by A61L31/084 or A61L31/086 · CPC title

  • Other inorganic materials not covered by A61L31/022 - A61L31/026 · CPC title

  • of other specific inorganic materials not covered by A61L31/122 or A61L31/123 · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

  • Coatings comprising two or more layers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2023414841A1 cover?
A health care and/or entertainment device protective film may be configured to contact human skin, e.g., to limit the transmission of infection by bacteria, fungi, protozoa, prions, and/or viruses. The film may be formed as a nanocomposite film including at least 75 wt. %, relative to total organic matrix weight, of polyethylene, silver particles, and TiO2 particles, wherein the silver particle…
Who is the assignee on this patent?
Univ Imam Abdulrahman Bin Faisal
What technology area does this patent fall under?
Primary CPC classification A61L31/088. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).